close print view
New Molecular Test for Trichomonas Available
On November 18, 2013, the Michigan Department of Community Health Bureau of Laboratories (MDCH BOL) will begin offering a nucleic acid amplified test (NAAT) for Trichomonas vaginalis (T. vaginalis) on a fee-for-service basis. The test will be available for $11.50 when ordered in conjunction with non-culture testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) or CT only. Testing will be available on endocervical, vaginal swabs and urine specimens from symptomatic and asymptomatic women. The test is performed on the same specimen collected for CT/GC testing.
See the full announcement.
Medicaid Claims to Require Physician's NPI
Effective October 1, 2013, the ordering physician’s NPI is required by CHAMPS for all Medicaid claims submitted to the MDCH Bureau of Laboratories. In addition, the ordering physician must be enrolled in CHAMPS. Failure to supply the ordering physician’s NPI on the test requisition form AND enroll as a provider in CHAMPS will result in a rejected claim. Your office will be billed if Medicaid rejects the claim.
If you are not enrolled as a provider then call 800-292-2550 and select option 3 to enroll in CHAMPS. Enrollment is free of charge.
Hepatitis C - Important ChangesThe testing algorithm for Hepatitis C virus (HCV) will be changing as of November 1, 2013.
HCV testing will now consist of two tests, a serologic screening test and a molecular test.
The serologic screening test detects the presence of antibody to HCV, but does not differentiate between past infection, current infection, or possible false-positive results. Specimens with demonstrable antibody to HCV will automatically be tested by the molecular test for Hepatitis C viral RNA. The presence of Hepatitis C viral RNA confirms current HCV infection.
It is critical for the molecular test that specimens are kept cold (or frozen) until testing is performed. Specimens must be transported at 2 to 8 ºC or colder. Any specimen that is not cold when received at the MDCH laboratory will be screened for antibody to HCV, but antibody-positive specimens will be reported as unsatisfactory for molecular testing.
See the full announcement.
BOL Recieves Contract to Investigate Tuberculosis NationwideThe MDCH Bureau of Laboratories (BOL) has been awarded a $3.6 million contract to provide Mycobacterium tuberculosis (TB) genotyping for the entire United States from the Centers for Disease Control and Prevention (CDC). The laboratory will receive specimens from all 50 states to perform this molecular genetic testing making Michigan a global leader. TB genotyping results used in combination with epidemiologic investigations help to establish important links between one patient and another. This information can lead to the discovery of unsuspected TB cases and help prevent further spread of illness. MDCH BOL has been involved with genotping of Mycobacterium tuberculosis since the technique was first developed in the 1990s. This is the third genotyping award made to the BOL.
Laboratory System PodcastsAs a part of the May, 2013, Laboratory System Advisory Group meeting, a series of podcasts were developed on the value of the Michigan Laboratory System. These podcasts can be viewed in either QuickTime or RealPlayer.
Your Public Health Laboratory System - Michigan
The Value of the State Public Health Laboratory
The Hospital Laboratory Role in the Public Health Laboratory System
The County Health Department's Role in the Public Health Laboratory System
State Public Health Role in Emergency Response
New Chemical Threat Response Training Coordinator
On April 15, 2013, Teresa Miller assumed the role of the Bureau of Laboratories (BOL) Chemical Threat Response Training Coordinator. Teresa has been with the BOL for a number of years in various positions, lastly in the Quality Assurance Section. As Teresa steps into this new position, she will be contacting laboratories, local health departments, and other partners to schedule chemical exposure (threat) packaging and shipping training. Teresa can be reached at 517-241-0925 or MillerT28@michigan.gov
On-Demand training is also available through MiTRAIN at https://mi.train.org
Course title: Laboratory Response and Hospital Preparedness in a Chemical Exposure (Terrorism) Event
New CDC Submission Forms
CDC has initiated a new electronic process to submit specimens to CDC laboratories for testing.
Reminder: Specimens sent to CDC for testing must be submitted through the state public health laboratories, with very rare exceptions.
Please share this information with your laboratory send-outs staff and request they discard and delete all older versions of CDC form 50.34.
Results Reporting from CDC:
New Test Directory
One exciting new feature of CDC's electronic submission process will be a drop-down test directory menu. We anticipate this test directory will be very helpful in preparing the submission forms. This new directory can be found at http://www.cdc.gov/laboratory/specimen-submission/form.html
New Laboratory Director
Dr. Sandip Shah has been selected as the new Director of the State Laboratory. Since August, Dr. Shah has filled the role as Acting Director. Dr. Shah worked as a microbiologist with the Michigan Department of Public Health in 1987 and progressed to Laboratory Scientist Manager; Director, Division of Infectious Diseases; and now Laboratory Director. He holds an Associate's Degree in Biology from the University of London; a Bachelor's Degree in Microbiology/Chemistry from Gujarat University in Ahmedabad; a Master's Degree in Microbiology/Biochemistry from Maharaja Sayajirao University in Baroda; and a Doctoral Degree from Michigan State University College of Veterinary Medicine in large animal clinical sciences/microbiology. Additional Certificates and Licenses include ASCP (Medical Technology from the American Society for Clinical Pathology) issued in 1982; CST 370 (PC coordinator and system specialist) issued in 2000 by PTD - Lansing Computer Institute; and HCLD (High Complexity Clinical Lab Director) issued in 2010.
MDCH Confirmatory Testing for Carbapenem-Resistant Enterobacteriaceae (CRE)
The MDCH Bureau of Laboratories has received a grant to develop non-automated AST capacity in state public health laboratories for CRE and VRSA to provide confirmatory testing for clinical laboratories within their jurisdiction. A webinar was held on December 11, 2012 to discuss the project design and the clinical laboratory role.
Multistate Outbreak of Fungal Meningitis Cases Resulting From Potentially Contaminated Steroid Injections
Fungal Meningitis Cases Resulting From Potentially Contaminated Steroid Injections- Oct 5th
For updated information regarding this outbreak, go to http://www.cdc.gov/hai/outbreaks/meningitis.html
Clinical Partner's Influenza Call
The Bureau of Laboratories hosted a Clinical Partner's Influenza Conference Call on September 11, 2012. If you missed the call, check out the recording. This recording is approximately 21 minutes long.
First Case of Influenza A (H3N2v) Detected in Michigan
The first case of variant H3N2 influenza infection in Michigan has been reported in a Washtenaw County child. State laboratory results indicate the child has tested positive for influenza A (H3N2) variant, or H3N2v. The child, who had recent exposure to swine at the Ingham County Fair, experienced mild illness and was not hospitalized. The state laboratory results were sent to the Centers for Disease Control and Prevention (CDC) for confirmatory testing.
The following guidance outlines the MDCH recommendations for influenza surveillance, reporting and testing for laboratories and will assist in characterizing the current H3N2v outbreak and virus transmissibility.
Laboratory Director Change
On August 12, 2012, Dr. Frances Pouch Downes stepped down as Laboratory Director for the Michigan Department of Community Health Bureau of Laboratories (BOL). Dr. Downes had been Laboratory Director for the past 13 years and with the BOL for a total of 22 years. Under her leadership, the laboratory was successful in grant funding and technology acquisition, and, more recently, improved efficiency during times of economic stress. Dr. Downes' successful strategies included 1) continuation of essential testing services, 2) seeking out creative means to offer services, and 3) excellence in all you do. Dr. Downes has joined the Michigan State University faculty training and inspiring future scientists.
Sandip Shah, Ph.D., HCLD(ABB) has been selected as Laboratory Director and Acting Bureau Administrator beginning August 13, 2012. Dr. Shah is committed to continuing the policies and legacy Dr. Dowens has instilled upon the state laboratory.
Blood Lead Testing Collection Videos
Filter Paper Collection Video- This video provides a step-by-step demonstration of proper specimen collection using filter paper. It can be viewed at http://youtu.be/WAKcq3N3mow.
Capillary Draw Collection Video- This video provides a step-by-step demonstration of proper specimen collection using a capillary vacutainer. It can be viewed at http://youtu.be/TkYGbJI2VY4.
Changes in Testing Services
Newborn Screening Program Adds SCID Testing
The Michigan Newborn Screening Laboratory began testing for Severe Combined Immunodeficiency (SCID) on October 1, 2011. Information can be found on the Michigan Newborn Screening Program page.
Virtual Tour Available
Have you ever wanted to tour the State Public Health Laboratory? Take a virtual tour now by viewing our new video.
MDCH Laboratory Research Collaboration: ERIN
MDCH Announces Changes in Regional Laboratory QC Requirements
On 3/15/2011, the Michigan Regional Laboratory System (MRLS) announced changes to the Quality Control requirments for waived testing based upon the requirements of the test manufacturer.
Michigan Regional Laboratory System Changes
For almost two decades the Michigan Regional Laboratory System (MRLS) has provided a structure of quality assurance for local public health agencies performing testing on human specimens in a non-traditional laboratory or point-of-care setting. The MRLS has enabled local public health agencies to meet the federal regulatory requirements of CLIA'88. However, in the years between the inception of MRLS and now, there have been profound changes in diagnostic technology and state and local public health resources. Read more in the reorganizational letter below.
Bureau of Laboratories Annual Reports
Copyright © 2001-2013 State of Michigan